| 2978- | CUR, | N-acetyl cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of Sp1 reduction in A549 cells |
| - | in-vitro, | Lung, | A549 |
| 2977- | CUR, | Curcumin Down-Regulates Toll-Like Receptor-2 Gene Expression and Function in Human Cystic Fibrosis Bronchial Epithelial Cells |
| - | in-vitro, | CF, | NA |
| 2976- | CUR, | Curcumin suppresses the proliferation of oral squamous cell carcinoma through a specificity protein 1/nuclear factor‑κB‑dependent pathway |
| - | in-vitro, | Oral, | HSC3 | - | in-vitro, | HNSCC, | CAL33 |
| 2975- | CUR, | Curcumin inhibits proliferation, migration and neointimal formation of vascular smooth muscle via activating miR-22 |
| - | in-vivo, | Nor, | NA |
| 2974- | CUR, | Curcumin Suppresses Metastasis via Sp-1, FAK Inhibition, and E-Cadherin Upregulation in Colorectal Cancer |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT29 | - | in-vitro, | CRC, | HCT15 | - | in-vitro, | CRC, | COLO205 | - | in-vitro, | CRC, | SW-620 | - | in-vivo, | NA, | NA |
| 6238- | CUSP9, | A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3 |
| - | Trial, | GBM, | NA |
| 6235- | CUSP9, | Exhaustive in vitro evaluation of the 9-drug cocktail CUSP9 for treatment of glioblastoma |
| - | in-vitro, | GBM, | NA |
| 6236- | CUSP9, | EP, | Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro |
| - | in-vitro, | GBM, | U251 |
| - | in-vitro, | GBM, | NA |
| 6234- | CUSP9, | In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma |
| - | Human, | GBM, | NA |
| - | Review, | GBM, | NA |
| 6239- | CUSP9, | The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy |
| - | in-vitro, | GBM, | NA |
| 6240- | CUSP9, | A Pilot Clinical Study of CUSP9v3: Nine Repurposed Drugs Combined With Temozolomide for the Treatment of Recurrent Glioblastoma |
| - | Human, | GBM, | NA |
| 6241- | CUSP9, | RECURRENT GLIOBLASTOMA: INITIAL EXPERIENCES WITH COMPASSIONATE-USE CUSP9v3/v4 |
| - | Trial, | GBM, | NA |
| - | Analysis, | GBM, | NA |
| 9091- | CV, | Chlorella vulgaris as a functional food and nutraceutical: bioactive composition, health-promoting mechanisms, applications, and current challenges |
| - | Review, | Nor, | NA |
| 9096- | CV, | Photoautotrophically Grown Chlorella vulgaris Shows Genotoxic Potential but No Apoptotic Effect in Epithelial Cells |
| - | in-vitro, | CRC, | HT-29 | - | in-vitro, | Colon, | Caco-2 |
| 9092- | CV, | I3C, | Anticancer and Antimicrobial Activity of Chlorella vulgaris BA02 Algae Extract Containing Indole-3-Acetic Acid |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | ZR-75-1 | - | in-vitro, | BC, | MDA-MB-231 |
| 9093- | CV, | Microalga Chlorella sp. extract induced apoptotic cell death of cholangiocarcinoma via AKT/mTOR signaling pathway |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Liver, | HUH7 | - | in-vitro, | CCA, | KKU-100 |
| 9094- | CV, | Chlorella vulgaris Induces Apoptosis of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 9095- | CV, | Hot water extract of Chlorella vulgaris induced DNA damage and apoptosis |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Nor, | WRL68 |
| - | Trial, | Nor, | NA |
| 9098- | CV, | A Single Dose of Marine Chlorella vulgaris Increases Plasma Concentrations of Lutein, β-Carotene and Zeaxanthin in Healthy Male Volunteers |
| - | Study, | Nor, | NA |
| 9099- | CV, | Effect of a hot water extract of Chlorella vulgaris on proliferation of IEC-6 cells |
| - | in-vitro, | Nor, | IEC-6 |
| 9100- | CV, | Oral administration of Chlorella vulgaris augments concomitant antitumor immunity |
| - | in-vivo, | Var, | NA |
| 9101- | CV, | Antineoplastic effects of Chlorella pyrenoidosa in the breast cancer model |
| - | vitro+vivo, | BC, | MCF7 |
| - | Review, | LiverDam, | NA |
| 9103- | CV, | Cisplatin, | Protective Impacts of Chlorella vulgaris on Cisplatin-Induced Toxicity in Liver, Kidney, and Spleen of Rats: Role of Oxidative Stress, Inflammation, and Nrf2 Modulation |
| - | in-vivo, | Nor, | NA |
| 9104- | CV, | SDT, | PDT, | Engineered microalgae for photo-sonodynamic synergistic therapy in breast cancer treatment |
| - | Study, | BC, | NA |
| 9105- | CV, | AgNPs, | Apoptosis induction in colon cancer cells (SW480) by BiFe2O4@Ag nanocomposite synthesized from Chlorella vulgaris extract and evaluation the expression of CASP8, BAX and BCL2 genes |
| - | in-vitro, | Colon, | SW480 |
| 9106- | CV, | Effect of supplementation with Chlorella vulgaris on lipid profile in adults: A systematic review and dose-response meta-analysis of randomized controlled trials |
| - | Review, | Nor, | NA |
| 9107- | CV, | VitB1/Thiamine, | Assessment of Antioxidant and Anticancer Activities of Microgreen Alga Chlorella vulgaris and Its Blend with Different Vitamins |
| - | in-vitro, | Var, | PC3 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | CRC, | HCT116 |
| 9108- | CV, | The influence of chlorella and its hot water extract supplementation on quality of life in patients with breast cancer |
| - | Trial, | BC, | NA |
| 9109- | CV, | Salivary secretory immunoglobulin A secretion increases after 4-weeks ingestion of chlorella-derived multicomponent supplement in humans: a randomized cross over study |
| - | Trial, | Nor, | NA |
| 9110- | CV, | Antiproliferative effects of carotenoids extracted from Chlorella ellipsoidea and Chlorella vulgaris on human colon cancer cells |
| - | in-vitro, | CRC, | HCT116 |
| 9037- | CV, | SP, | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| - | Review, | Nor, | NA |
| 6249- | Cyc, | Cyclopamine tartrate, an inhibitor of Hedgehog signaling, strongly interferes with mitochondrial function and suppresses aerobic respiration in lung cancer cells |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | NSCLC, | H1299 |
| 6242- | Cyc, | The teratogenic Veratrum alkaloid cyclopamine inhibits Sonic hedgehog signal transduction |
| - | in-vivo, | Nor, | NA |
| 6243- | Cyc, | Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened |
| - | Study, | Var, | NA |
| 6244- | Cyc, | Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours |
| - | in-vivo, | Var, | NA |
| 6245- | Cyc, | Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers |
| - | vitro+vivo, | PC, | NA |
| 6246- | Cyc, | Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 6247- | Cyc, | Sonic Hedgehog Pathway Contributes to Gastric Cancer Cell Growth and Proliferation |
| - | vitro+vivo, | GC, | MKN45 |
| 6248- | Cyc, | The Hedgehog Inhibitor Cyclopamine Reduces β-Catenin-Tcf Transcriptional Activity, Induces E-Cadherin Expression, and Reduces Invasion in Colorectal Cancer Cells |
| - | in-vitro, | CRC, | NA |
| 6250- | Cyc, | Dose- and route-dependent teratogenicity, toxicity, and pharmacokinetic profiles of the hedgehog signaling antagonist cyclopamine in the mouse |
| - | in-vivo, | Nor, | NA |
| 6251- | Cyc, | I only have eye for ewe: the discovery of cyclopamine and development of Hedgehog pathway-targeting drugs |
| - | Review, | Var, | NA |
| 6252- | Cyc, | Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance |
| - | Review, | Var, | NA |
| 16- | Cyc, | RES, | Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis |
| - | in-vitro, | GC, | SGC-7901 |
| 7442- | CYN, | Cynaropicrin induces the apoptosis of colorectal cancer cells by elevating reactive oxygen species and activating the JNK/p38 MAPK |
| - | in-vitro, | CRC, | HCT116 |
| 7452- | CYN, | Cynaropicrin inhibits pancreatic cancer cell viability and disrupts cellular redox homeostasis |
| - | in-vitro, | PC, | PANC1 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid